The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 3.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 22%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (19 analysts) rates it buy, with a mean price target of $49.
Las Vegas Sands
LVS · a US exchange · USD · Market cap $26.4B · 41,000 employees
Las Vegas Sands Corp., together with its subsidiaries, owns, develops, and operates integrated resorts in Macao and Singapore.
FAIL · Does not pass the screenPrice as of 19 Nov 2026Daily close, not a live quote
Screened 2026-11-19 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price39.33 USD at the 19 Nov 2026 close
- Our value readUndervalued vs our fair value, as of 19 Nov 2026
- Our regime readMarkup, as of 15 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans heavily to calls (put/call 0.48)
- Last reviewed19 Nov 2026 (1 day ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $51.06 to $78.54, base estimate $59.04 (screen dated 2026-11-19).
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning political buying, disclosed 2026-09-25
- Options put/call open interest 0.48, read 2026-11-18
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
Las Vegas Sands holds its Markup at $39.33. The statistical read favours the sellers, held for 70 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the sellers, held for 70 days |
| Price at the screen | $39.33 |
| Valuation | 16.73 trailing · 13.19 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 0.75 |
Five Screens: LVS's Results
FAIL. Business activity screen
| Test | Figure | Limit | Status |
|---|---|---|---|
| Business activity | Excluded | Permissible core business | Fail |
Definitions, sources and threshold rules: ticker values-screen methodology.
The Ethical ReadWhy It Falls Short, in Plain English
Las Vegas Sands does not clear the screen at the business-activity stage. It operates in gambling, so the financial ratios are not the deciding factor here.
Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when LVS's ethical verdict changes
Today LVS does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 19 Nov 2026: it trades at roughly a 33% discount to our $59.04 fair value, moderate competitive moat.
Model construction and limits: fair-value methodology.
Fair value range in USD, drawn from the 2026-11-19 screen. The gold marker is the market price at the same screen. A 33.4% discount to the base estimate.
Third-party analyst targets: 19 covering, consensus Buy. The average target sits +27% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $59.04, with a range of $51.06 to $78.54, dated to the 2026-11-19 screen.
How our estimate and third-party targets differ.
The Business, in Plain WordsMacau Casinos Look Cheap But Fail Ethics
Picture the ferry from Hong Kong pulling into Macau, packed with day trippers chasing the slots and baccarat tables inside Venetian and Parisian resorts. Las Vegas Sands runs those integrated casinos across Macau and Singapore, a business that posted 25% revenue growth and a 13% profit margin last year.
We pass anyway. The 12.4x forward earnings multiple and 90% ROE look attractive on paper, yet the stock fails our business activity screen outright. Moderate moat or not, that single ethical breach ends the conversation before valuation enters the room.
Cyclical demand tied to Chinese travel policy adds real volatility, and any slowdown in high-roller volumes would hit earnings fast. Nineteen analysts still lean buy with a $67 median target, but the ethical red flag overrides the apparent margin of safety. Analysis, not advice.
| Forward P/E | 13.2xreasonably valued |
| Trailing P/E | 16.7xreasonably valued |
| EPS, trailing | 2.44 |
| EPS, forward | 3.09 |
| Revenue growth | -3.5%revenue is shrinking |
| Profit margin | 11.8%thin but positive margins |
| Return on equity | 207.1%an exceptional return on shareholder capital |
| FCF yield | 7.97% |
| Dividend yield | 3.06% |
| Current ratio | 0.83below 1: short-term bills exceed liquid assets |
| Beta | 0.75steadier than the market |
| Short interest, float | 0.15% |
| 52-week range | 35.03 - 70.45 |
| Moat | MODERATE |
| Market cap | $26.4B |
| Employees | 41,000 |
Metric definitions and interpretation rules: ticker-page methodology.
Every Entry, As Written
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 6.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 22%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (19 analysts) rates it buy, with a mean price target of $50.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 22%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (19 analysts) rates it buy, with a mean price target of $50.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 22%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (19 analysts) rates it buy, with a mean price target of $50.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 22%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (19 analysts) rates it buy, with a mean price target of $55. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 22%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (19 analysts) rates it buy, with a mean price target of $55. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 22%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (19 analysts) rates it buy, with a mean price target of $57. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 22%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (19 analysts) rates it buy, with a mean price target of $57. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 22%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (19 analysts) rates it buy, with a mean price target of $57. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 5.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 22%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (19 analysts) rates it buy, with a mean price target of $58. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Tesla fund makes surprise Microsoft bet, keeps Nvidia stake Yahoo Finance · 8d ago
- What Could Surprise Carnival Stock Investors On The Upside? Yahoo Finance · 9d ago
- Sands China Performing Arts Programme Presents: 'Macau Band Directors Association 30th Anniversary Concert' Yahoo Finance · 9d ago
- How Long Should You Wait For Carnival Stock To Recover? Yahoo Finance · 14d ago
- Do Wall Street Analysts Like Las Vegas Sands Stock? Yahoo Finance · 14d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-14 | LI ALAIN | Director | 3,948 | · | |
| 2026-05-14 | PANT MUKTESH | Director | 3,948 | · | |
| 2026-05-14 | KRAMER LEWIS | Director | 3,948 | · | |
| 2026-05-14 | BESCA MARK M. | Director | 3,948 | · | |
| 2026-05-14 | CHAFETZ IRWIN | Director | 3,948 | · | |
| 2026-05-14 | FORMAN CHARLES D | Director | 3,948 | · | |
| 2026-05-14 | CHAU MICHELINE | Director | 3,948 | · | |
| 2026-04-27 | FORMAN CHARLES D | Director | 11,400 | $616,626 | |
| 2026-03-17 | DUMONT PATRICK | Chief Executive Officer | 60,165 | $3,294,034 | |
| 2026-03-17 | DUMONT PATRICK | Chief Executive Officer | 61,740 | $3,243,202 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-09-25 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-09-25 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-09-25 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-09-25 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-09-11 | Ro Khanna | Democrat | sell | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $37.70 | +4.2% | $0.30 | $1,050 | +5.0% |
| 2 months | $39.66 | -1.0% | $0.30 | $998 | -0.2% |
| 3 months | $45.60 | -13.9% | $0.30 | $868 | -13.2% |
| 6 months | $48.72 | -19.4% | $0.60 | $818 | -18.2% |
| 1 year | $63.15 | -37.8% | $1.20 | $641 | -35.9% |
| 2 years | $46.90 | -16.3% | $2.20 | $884 | -11.6% |
| 3 years | $46.03 | -14.7% | $3.00 | $918 | -8.2% |
| 5 years | $35.61 | +10.3% | $3.40 | $1,198 | +19.8% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever LVS does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.